Forum Replies Created
-
Posts
-
my bad
you have put your finger on a small bug in the calculation of the growth of the PM dividend
I corrected it and it will be updated next weekend in my portfolio
for the distribution ratio you can also find it in my portfolio or on dividendinvestor
it is currently 64%
It's a bit indiscreet indeed
As for me, I am not looking to reach a level of wealth but a level of income… that is what makes all the difference with increasing dividends. You have all the details of the distribution of my stock portfolio in my portfolio and the details of the income received and referred to in my performance.
Yes the banker should be able to answer you! He is paid for that.
Otherwise another possibility: you don’t declare anything…
Well, it's no joke in France! If you're treated like that, I'm not surprised that you prefer to hide everything from the taxman!
I bought some Philip Morris stock recently. If you are looking to invest in cigarette companies, this may be the most promising company. See for example: http://seekingalpha.com/article/1407921-the-bull-case-for-this-tobacco-company.
In my opinion it is a good choice.
I recently bought MSFT shares because I think it's a good investment for growing dividends: 10+ years of paying, yield around 3% and the company has enough to keep paying. For Apple, I wonder if this company will become a dividend culture in the future...
Roche, ABB, Novartis, Zurich and Phillip Morris (each 7-8% in the portfolio). My US positions are twice as numerous as the CH positions, but half as large.
All the lines of my portfolio are more or less equivalent in terms of weight.
I'm not a big fan of either, but I'd obviously choose MSFT because it's becoming a mature company, a real cash cow, which has been distributing and increasing its dividend for several years.
But I have more and more trouble with the Windows monopoly that is seriously starting to annoy me with these updates where you have to relearn everything every time, like with Windows 8 which I find really bad. By trying to copy Apple, Microsoft is burning its wings. And then we are also fed up with a PC that runs very well on an operating system at the beginning invariably slowing down over time. It is as if Microsoft and PC manufacturers had made an alliance so that we change machines and systems every three years. And in the end we are always using the same programs...
The growth is not too bad indeed, but it is not extraordinary either (5.58%). Other growing dividends do much better. On the other hand, I think that this growth will increase somewhat in the future. And it is true that the yield is interesting.
What bothers me most about PM is the volatility (28.94%).
VStax for example manages a good part of US stocks. On the other hand, there is no Templeton or Vanguard.
At the time I had a UBS fund like that, with reinvestment of income. But I sold it because it no longer corresponded to my strategy… and then I find it quite opaque.
Tax software, sometimes even government-provided software, automatically calculates the taxable return for you, even if the money is reinvested in the fund.
PFE doesn't seem so bad to me, the profit is progressing well and covers the dividend quite well. It's true that the PER is a bit high on the other hand. You have already sold Sanofi and Merck, perhaps you can postpone your decision for PFE a little, in order to spread the "risk" of selling. Regarding ABT, I am also holding on.
For GE it's a nice value, not expensive at the moment. It doesn't really fit my risk style though.
Good morning
Although I am generally more of a supporter of holding dividend stocks, I can understand your decision to sell SAN and MRK. It is a nice capital gain, the market is very high at the moment and the stocks no longer have a huge dividend growth potential.
As for the new liquidity available, I am in the same situation as you at the moment. I have quite a bit of cash and I am lying in wait, waiting for a correction that becomes really necessary. I also have a few stocks in my sights that remain at attractive valuations, such as DWX (US ETF), Casino in Paris and on the Swiss market Swisscom and Zurich Insurance.
